ProteoTech

Description

ProteoTech is dedicated to discover disease-modifying treatments for major human diseases. Since 1996, ProteoTech has been focused on discovering novel small molecule compounds and peptide therapeutics that will result in a positive impact on the world's aging population and on rare disease indications.

The Company believes that specific and newly identified compounds within these classes will lead to exciting new therapies for the treatment of amyloid diseases. ProteoTech's team of scientists is dedicated to improving the health of individuals targeted with these dreaded diseases.

ProteoTech Inc. , is a private drug development Company that is located in the Seattle, WA area (Kirkland, WA), and is focused on targeting misfolded proteins and amyloid diseases. ProteoTech is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease , Parkinson's disease , type 2 diabetes and systemic amyloid disease (including AL, TTR and AA amyloidosis).

Company contacts

Companies nearby